Lung leukocytes promote alveolar epithelial regeneration after severe injury
Lung leukocytes promote alveolar epithelial regeneration after severe injury
批准号:
10396022
负责人:
Nicholas Arpaia
金额:
$62.04万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-01 至 2025-04-30
关键词:
AblationAcuteAcute Lung InjuryAlveolarAmphiregulinAnatomyBindingCellsChronicCuesDevelopmentDisease modelDistalEnvironmentEpidermal Growth Factor ReceptorEpithelialEpithelial CellsExhibitsFunctional disorderFutureGene ExpressionGoalsGrowth FactorHomeostasisImageImmuneImmune responseImmune signalingImmune systemImpairmentInfectionInflammationInflammation MediatorsInflammatoryInjuryKineticsLeukocytesLigandsLinkLungLung diseasesLymphocyteMediatingMesenchymalMetabolicModelingMolecularMusNatural regenerationOrganOutcomePathogenicityPatternPhasePhysiologicalPlayPopulationProcessProductionRegenerative MedicineRegulationRegulatory T-LymphocyteReport (document)ResolutionRoleSeveritiesSignal TransductionSourceSpatial DistributionSterilityStimulusStructure of parenchyma of lungSupporting CellT-LymphocyteTestingTissuesTumor ImmunityViral Respiratory Tract InfectionWound modelsairway regenerationalveolar epitheliumbasecell typeepithelial stem cellepithelium regenerationimmunological diversityin vivoinfluenza infectioninfluenzavirusinterdisciplinary approachlung injurylung preservationlung regenerationlung repairorgan growthpathogenprogenitorprogramsprotective factorspulmonary functionrecruitregenerativerepairedresponserestorationsevere injuryskin woundstemstem cell populationstem cellstherapeutic candidatetherapeutic developmenttissue injurytissue regenerationtissue repairtoolvirus genetics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
It has become increasingly appreciated that lymphocytes within non-lymphoid tissues exhibit unique effector
programs that extend beyond their roles in anti-pathogen and anti-tumor immunity. Such non-immune functions,
including the regulation of metabolic homeostasis and tissue repair, highlight the diversity of immunological
signals that can be elaborated in a tissue-specific manner to modify physiological and developmental parameters
within a given niche. To achieve these diverse regulatory roles, tissue-localized leukocytes interact with
specialized non-lymphoid cells that define the organ’s function, triggering niche-specific effector programs in
response to perturbations within the tissue microenvironment. In support of this mechanism, a recently described
population of lung regulatory T (Treg) cells were shown to play a pronounced tissue-protective role during the
early stages of acute lung injury caused by influenza virus infection in mice. Through their production of the
epidermal growth factor receptor (EGFR) ligand, amphiregulin, these Treg cells support epithelial barrier
regeneration and preserve lung function. Although these findings uncovered an important and previously
unknown role for Treg cell–derived amphiregulin, the mechanistic details of how amphiregulin influences lung
repair remained undetermined. Preliminary studies indicate that in response to lung injury caused by other
damaging stimuli, infiltrating leukocyte populations other than regulatory T cells produce amphiregulin. Further
inspection has suggested that amphiregulin-producing leukocytes may guide alveolar epithelial regeneration by
interacting with specific lung mesenchymal and epithelial stem/progenitor cell populations that orchestrate
discrete steps of the repair process. To this end, the major goals of this proposal are to 1) characterize
interactions between amphiregulin-producing lung leukocytes and resident mesenchymal and epithelial
stem/progenitor cells, 2) identify the molecular basis of these interactions and define their relative significance
for restoring normal lung function, and 3) determine how these cellular interactions are influenced by the severity
or type of damaging stimuli. Successful completion of this project will broaden our understanding of the role of
tissue-specific immune responses in directing tissue regeneration and support the development of future
strategies that seek to stimulate these processes to treat lung disease and restore normal organ homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Programmable encapsulation systems to improve delivery of therapeutic bacteria
-
批准号:10639259
-
项目类别:
-
资助金额:$61.39万
-
财政年份:2023
-
负责人:Nicholas Arpaia
-
依托单位:
Treating colon cancer by regulating intestinal immunity through microbial metabolism
-
批准号:10189065
-
项目类别:
-
资助金额:$56.14万
-
财政年份:2021
-
负责人:Nicholas Arpaia
-
依托单位:
Treating colon cancer by regulating intestinal immunity through microbial metabolism
-
批准号:10618990
-
项目类别:
-
资助金额:$55.41万
-
财政年份:2021
-
负责人:Nicholas Arpaia
-
依托单位:
Treating colon cancer by regulating intestinal immunity through microbial metabolism
-
批准号:10410442
-
项目类别:
-
资助金额:$55.41万
-
财政年份:2021
-
负责人:Nicholas Arpaia
-
依托单位:
Engineering immunotherapeutic probiotics to mitigate irAE
-
批准号:10556326
-
项目类别:
-
资助金额:$59.97万
-
财政年份:2020
-
负责人:Nicholas Arpaia
-
依托单位:
Modulation of the tumor microenvironment with probiotic therapies
-
批准号:10737757
-
项目类别:
-
资助金额:$8.66万
-
财政年份:2020
-
负责人:Nicholas Arpaia
-
依托单位:
Modulation of the tumor microenvironment with probiotic therapies
-
批准号:10380671
-
项目类别:
-
资助金额:$56.13万
-
财政年份:2020
-
负责人:Nicholas Arpaia
-
依托单位:
Lung leukocytes promote alveolar epithelial regeneration after severe injury
-
批准号:10666350
-
项目类别:
-
资助金额:$62.04万
-
财政年份:2020
-
负责人:Nicholas Arpaia
-
依托单位:
Engineering immunotherapeutic probiotics to mitigate irAE
-
批准号:9921971
-
项目类别:
-
资助金额:$58.63万
-
财政年份:2020
-
负责人:Nicholas Arpaia
-
依托单位:
Lung leukocytes promote alveolar epithelial regeneration after severe injury
-
批准号:9977404
-
项目类别:
-
资助金额:$63.59万
-
财政年份:2020
-
负责人:Nicholas Arpaia
-
依托单位:
Lung leukocytes promote alveolar epithelial regeneration after severe injury
-
批准号:10225703
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2020
-
负责人:Nicholas Arpaia
-
依托单位:
Engineering immunotherapeutic probiotics to mitigate irAE
-
批准号:10302262
-
项目类别:
-
资助金额:$58.41万
-
财政年份:2020
-
负责人:Nicholas Arpaia
-
依托单位:
Modulation of the tumor microenvironment with probiotic therapies
-
批准号:10524173
-
项目类别:
-
资助金额:$8.58万
-
财政年份:2020
-
负责人:Nicholas Arpaia
-
依托单位:
Modulation of the tumor microenvironment with probiotic therapies
-
批准号:10610407
-
项目类别:
-
资助金额:$55.19万
-
财政年份:2020
-
负责人:Nicholas Arpaia
-
依托单位:
Mechanisms mediating tissue repair by leukocytes during influenza virus infection
-
批准号:9224081
-
项目类别:
-
资助金额:$16.14万
-
财政年份:2017
-
负责人:Nicholas Arpaia
-
依托单位:
Mechanisms mediating tissue repair by leukocytes during influenza virus infection
-
批准号:9481798
-
项目类别:
-
资助金额:$10.45万
-
财政年份:2017
-
负责人:Nicholas Arpaia
-
依托单位:
海外基金